Biotechnology
Marshall Edwards, Inc. today announced that it has been granted an Investigative New Drug approval by the United States Food and Drug Administration to undertake clinical studies with triphendiol as a chemosensitising agent in combination with gemcitabin
24 hours ago
Phylonix Pharmaceuticals, Inc. today announced that it has been awarded a $1,250,369 Phase II Small Business Innovation Research Grant from the National Institute of General Medical Sciences of the National Institutes of Health to develop in vivo zebrafi
24 hours ago
Cardica, Inc. today announced the webcast of a robot-assisted, closed-chest coronary artery bypass graft procedure performed by internationally renowned cardiothoracic surgeon Sudhir Srivastava, M.D., of the University of Chicago Medical Center, using Ca
25 hours ago
Universal Detection Technology , a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, reported today that it has r
25 hours ago
Medpace, Inc. today announced the addition of Dr. Thomas G. Todaro, MD, JD, FACC, FCLM as an Executive Medical Director, continuing their strategy of building onto a strong existing therapeutic team of scientists. Dr. Todaro joins a group considered indu
25 hours ago
The Bariatric Center at Saint Francis Hospital and Medical Center is proud to offer a web cast featuring Laparoscopic Roux-en-Y Gastric Bypass Surgery.
27 hours ago
Skyepharma PLC announces European Product Approval
30 hours ago
The Medicines Company is scheduled to participate in the 27th Annual JP Morgan Healthcare Conference on Tuesday, January 13th, at 9am Pacific Time, 12:00pm Eastern Time. A company overview and outlook will be provided in the presentation.
39 hours ago
Novacea, Inc. announced today an upcoming special meeting of Novacea stockholders to vote on matters related to the proposed merger between Novacea and Transcept Pharmaceuticals, Inc. The meeting is scheduled to be held at 9:00 a.m. Pacific on Tuesday, J
40 hours ago
Toxin Alert Inc. was unable to file its audited financial statements and other material for the fiscal year ended June 30, 2008 by the statutory deadline of October 29, 2008 and a Management Cease Trade Order was issued by the relevant securities authori
42 hours ago
PHT Corporation, the leading provider of electronic patient reported outcome solutions used in more than 375 clinical trials worldwide, today announced TUV Rheinland of North America has recertified PHT as compliant with the ISO 9001:2000 standard. ISO 9
43 hours ago
PharmEng International Inc. , a full-service consulting and contract manufacturing company, today announced that Keata Pharma Inc. , its wholly owned subsidiary, has signed an agreement effective January 1, 2009 with a multi-national consumer healthcare
43 hours ago
Cord Blood America, Inc. , announced today that the Company will begin to engage its clients, prospective clients, shareholders and prospective investors via social media. Cord Blood America is currently on Twitter, Facebook and soon to be available on F
46 hours ago
GeneThera, Inc. , an innovator in the biotech marketplace, today released partial income projections for 2009 based on the new Johne's disease test. The projections released are only for GeneThera Diagnostic Laboratories, the US testing division of GeneT
47 hours ago
David H. Fater, President and CEO of Vicor Technologies, Inc., today announced that on December 29, 2008 Vicor Technologies received FDA 510 approval to market its PD2i Analyzer, permitting immediate commercialization of the technology. Vicor Technologie
47 hours ago
© Copyright 2009 Baret News
